2026 Q3 Portfolio Activity
In 2026 Q3, Foresite Capital Management IV, LLC maintained a portfolio of 7 distinct positions. The most significant new addition was VERACYTE, INC., now representing 3.65% of the total fund value. Conversely, Foresite Capital Management IV, LLC completely exited their position in Crinetics Pharmaceuticals, Inc.
Position History
hover any row below to update
Loading…
Total Positions
7
Quarter
2026 Q3
Top Holding
PHVS (60.1%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-7 of 7
Foresite Capital Management IV, LLC Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PHVS
Pharvaris N.V.
|
Healthcare | 60.14% | 56.95% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
4,778,581 | $151,576,589 |
$25.70
+25.6%
|
2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 18.69% | 20.98% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
714,695 | $47,105,547 |
$15.92
+225.1%
|
2018 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
RLAY
Relay Therapeut...
|
Healthcare | 8.95% | 8.06% |
#3
1
Prev: #4
|
5.6 |
—
|
no change | no change |
P
S
|
1,250,000 | $22,562,500 |
$34.92
-52.8%
|
2020 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
EIKN
Eikon Therapeut...
|
Healthcare | 6.20% | 8.74% |
#4
1
Prev: #3
|
4.0 |
—
|
no change | no change |
P
S
|
1,943,682 | $15,627,203 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VCYT
VERACYTE, INC.
|
Healthcare | 3.65% | — |
#5
Prev: #—
|
5.5 |
—
|
200,000 | — |
NEW
|
200,000 | $9,208,000 | 2019 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
XENE
Xenon Pharmaceu...
|
Healthcare | 2.36% | 3.33% |
#6
1
Prev: #5
|
1.9 |
—
|
no change | no change |
P
S
|
160,000 | $5,950,400 | 2018 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CRNX
Crinetics Pharm...
|
Healthcare | 0.00% | 1.93% |
Sold All 😨
(Was: #6) |
0.0 |
—
|
-150,000 | -100.0% |
CLOSED
|
— | $— | 2018 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-7 of 7 holdings